The spectrum of established and emerging treatment options for CHB is evaluated, organized around quantitative HBsAg (qHBsAg) as the axis for selecting and sequencing therapy, organized around quantitative HBsAg (qHBsAg) as the axis for selecting and sequencing therapy.
Shang-Chin Huang, J. Kao· Expert Review of Anti-Infect...· 1 citation
Older age, alcohol, T2DM, chronic HBV infection, and obesity were associated with advanced fibrosis, and risk factors and noninvasive score performance varied in nonelder subjects.
Chenshayang Huang, Shang-Chin Huang, Chia-Lin Kang et al.· Journal of Gastroenterology...· 0 citations
BACKGROUND
As hepatocellular carcinoma (HCC) etiologies shift from viral to non-viral, many at-risk patients lack surveillance in real-world practice. This study characterizes the clinical features and receipt of curative therapy in HCC patients with and without surveillance.
METHODS
A retrospective cohort study was...
Shao-Li Huang, Hsi-An Chen, Chun-Hsun Liao et al.· Journal of Gastroenterology...· 1 citation
While PET refines etiological diagnosis, p-tau217 serves as a robust predictor of amyloid status and cognitive trajectory, and integrating these biomarkers improves risk stratification and may facilitate patient selection for disease-modifying therapies.
Pu-Tien Chiang, Shao-Ying Cheng, Sung-Ju Hsueh et al.· Journal of Alzheimer's Disea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.